ArticlePCN reports : psychiatry and clinical neurosciences2025
Menstrual psychosis with a marked response to carbamazepine.
Article in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Menstrual psychosis with a marked response to carbamazepine.PCN reports : psychiatry and clinical neurosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Menstrual psychosis was first defined by Brockington in 1998 as a form of cycloid psychosis, the key features of which are an acute onset occurring against a background of normal mental functioning, brief duration, psychotic features, and a circadian periodicity that aligns with the menstrual cycle. Furthermore, menstrual psychosis is clearly distinguishable from menstrual syndrome and premenstrual dysphoric disorder, which are mood disorders related to the menstrual cycle, by the presence of psychotic symptoms. There are thus far only 80 reported cases of menstrual psychosis. As of yet, there is no consensus on its treatment, and antipsychotic and antidepressant therapies are considered ineffective. Case Presentation: We report herein a 17-year-old Japanese patient in whom psychotic symptoms appeared before, and resolved after, menstruation. The patient responded poorly to antipsychotic and antidepressant therapy, but carbamazepine administration led to a complete resolution of her symptoms. Conclusion: Carbamazepine may be effective in some patients with cycloid psychotic symptoms fulfilling the diagnostic criteria for menstrual psychosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.